SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Greenwich LifeSciences, Inc.
@GLSI_InsiderForm 4 Filing: Patel Snehal Buys $20,430 of $GLSI
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Greenwich LifeSciences, Inc.
Ticker: $GLSI
Transaction Value
$20,430
Price/Share: $13.62
transaction date
2026-07-27
Shares: 1,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Patel Snehal, holds the title of CEO and CFO at Greenwich LifeSciences, Inc..
On 2026-07-27, the insider transacted 1,500 shares.The shares were transacted at a weighted average price of $13.62 per share, resulting in a total market-relevant value of $20,430.
Executive Summary Summary
Patel Snehal (CEO and CFO) bought $20K of $GLSI
Post-Transaction Position: 5,609,202 shares
SEC Accession No: 0001493152-26-035085 (CIK: 1806920)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.